Vitrimark, Inc.

Location:MA, US
Speaker:Arijit Bose
Primary Industry:Pharma & Biotech
Executive Summary:Vitrimark, Inc. exploits the unique advantages provided by nanoscale cryoimaging of biofluids to identify ultrastructural biomarkers for utility and integration in the drug development process. Current methods for determining biomarkers involve functional assays. The fundamental premise in Vitrimark, Inc.’s technology is that ultrastructural changes precede functional changes and thus allow earlier detection potential. Morphology changes at nanoscale resolution will be correlated to functional and phenotypic changes. This approach alleviates biochemical assays that probe functional alterations in genes and proteins, and require a priori knowledge of specific target genes. Vitrimark\'s initial target is structural biomarkers for prostate cancer; it will then target prediabetes and diabetes.
Venture is:Seed Level


Corporate Presentations:

  • Air Products
  • BASF
  • Eastman Kodak Company
  • Genzyme
  • Goodrich
  • Hewlett-Packard
  • Honda
  • Medtronic
  • Merck
  • Sanyo

Reserved Presentations:

  • ExxonMobil
  • IBM

Partnering Events:
(full access included)

Platinum Sponsor

University of Hawaii

Press Sponsor

Business Wire

Commercialization Partner



Invest Australia AzTE Technology Enterprises

Media Sponsors

(joint with Nanotech 2007) Nature
Red Herring

Supporting Organizations

Boston University
Midwest Research University Network


“A major challenge for both the technology and the financial communities is finding a forum in which all parties can interact and explore possibilities for future innovation. TechConnect was created to fill this void, bringing both sides together under one roof into a setting that ultimately will help significant ground-breaking concepts come to life.”
Matthew Laudon, Co-Founder and Director of TechConnect